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Are Nike’s Vaporfly trainers the Emperor’s new shoes? Why placebo-controlled trials are needed to 
determine whether Nike Vaporfly trainers improve performance 
We are in a golden age of road running. In the past 6-months, 10 world records have been broken, 
including the men and women’s marathon. While breaking a world record is an incredible feat of 
human performance, the media attention of recent world record holders is not directed towards their 
physical and psychological ability, but of the shoes they wear.  
The previous 10 world records in road running have been achieved while wearing Nike’s Vaporfly 
trainers. These trainers have caused controversy, with some stating that such trainers undermine the 
ethos of sport. Nike have engineered a trainer that includes a carbon fibre plate and energy-returning 
foam that is purported to decrease the energetic cost of running, which in turn, allows an athlete to 
run faster for longer. However, although this piece of engineering may be a significant factor into the 
effectiveness of the trainer, one factor that has gone unnoticed is the athlete’s belief that the trainer 
improves performance. This is often referred to as the placebo effect.  
The placebo effect is a desirable outcome resulting from a person’s expected response to an 
ergogenic aid (e.g. sport supplements, ice baths and sports clothing). In our recent review of the 
placebo effect on sport performance, we found that an athlete’s belief can significantly improve 
performance by on average 5.1%. It is therefore likely that athletes’ wearing the Nike Vaporfly are 
benefitting not just from the engineering of the trainer, but from their belief that it improves 
performance.  
A question exists as to how much the placebo effect influences the effectiveness of Nike’s Vaporfly 
trainers. To help answer this, a need exists for appropriately controlled research. Placebo controlled, 
double-blind, randomised controlled trials are regarded as the gold standard for ascertaining the 
effectiveness of ergogenic aids. Currently, no study exists that has used this design to evaluate the 
effectiveness of Nike’s Vaporfly trainers. While a lack of evidence is different to evidence of lack of 
effect, caution is needed when making claims that a trainer is the reason for the number of world 
records being broken when there is a paucity of placebo-controlled evidence. There is a threat that 
without such evidence, an exaggeration of the effectiveness of the trainer will over emphasise its 
benefit and result in athletes believing that in order to compete with their competitors, they need to 
purchase a pair.  
Like the Emperor’s New Clothes, when the sport science community does not conduct appropriate 
research into the effectiveness of ergogenic aids, we run the risk of ignoring what exactly underpins 
the improvements in performance. Without placebo-controlled trials to determine effectiveness, 
there is a risk that the Emperor is wearing a pair of Nike Vaporfly trainers that are no better than the 
placebo effect.  
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